Patent assignee · CH · COMPANY

Baxalta Incorporated

152Patents
150Active
152Granted
58Portfolio score

Filing activity: Jan 27, 2006 → Oct 14, 2020 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
USD788936S1 Packaging unit for single medical device General 25 Active
USD788937S1 Packaging unit for single medical device General 21 Active
US10640741B2 Stirred tank reactor systems and methods of use Emerging Cross-Sectional Technologies 18 Active
US9540606B2 Stirred tank reactor systems and methods of use Emerging Cross-Sectional Technologies 17 Active
US9127265B2 Cell culture medium for ADAMTS protein expression Chemistry; Metallurgy 14 Active
US9358181B2 Assembly to facilitate user reconstitution Human Necessities 12 Active
US10301376B2 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase Emerging Cross-Sectional Technologies 12 Active
US9714411B2 Animal protein-free media for cultivation of cells Chemistry; Metallurgy 11 Active
US9809796B2 Animal protein-free media for cultivation of cells Chemistry; Metallurgy 11 Active
US10201586B2 TFPI inhibitors and methods of use Physics 10 Active
US9315560B2 Purification of VWF for increased removal of non-lipid enveloped viruses Chemistry; Metallurgy 10 Active
USD893046S1 Container unit General 10 Active
US10758599B2 Stabilized liquid and lyophilized ADAMTS13 formulations Emerging Cross-Sectional Technologies 10 Active
US9488625B2 Purification of factor VIII using a conductivity gradient Physics 10 Active
US10800816B2 TFPI inhibitors and methods of use Physics 10 Active
US10232022B2 Lyophilized recombinant VWF formulations Human Necessities 9 Active
US11081211B2 Method and apparatus for providing a pharmacokinetic drug dosing regimen Physics 9 Active
US9643998B2 Real time monitoring and control of protein production processes using impedance spectroscopy Emerging Cross-Sectional Technologies 9 Active
US9234051B2 Methods for fucoidan purification from seaweed extracts Chemistry; Metallurgy 9 Active
US11305000B2 Chimeric OspA genes, proteins and methods of use thereof Emerging Cross-Sectional Technologies 9 Active
US11020459B2 Factor VIII formulations Human Necessities 9 Active
US9758568B2 Oligopeptide-free cell culture media Emerging Cross-Sectional Technologies 9 Active
US9452108B2 Device for encouraging adherence to medication schedule and proper administration technique Human Necessities 7 Active
US9409971B2 Method of producing recombinant high molecular weight vWF in cell culture Chemistry; Metallurgy 7 Active
US9175068B2 Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use Chemistry; Metallurgy 6 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.